Highly accurate response prediction in high-risk early breast cancer patients using a biophysical simulation platform

被引：0
|
作者：
Frederick M. Howard
Gong He
Joseph R. Peterson
J. R. Pfeiffer
Tyler Earnest
Alexander T. Pearson
Hiroyuki Abe
John A. Cole
Rita Nanda
机构：
[1] University of Chicago,Department of Medicine
[2] SimBioSys,Department of Radiology
[3] University of Chicago,undefined
来源：
Breast Cancer Research and Treatment | 2022年 / 196卷
关键词：
Neoadjuvant chemotherapy; MRI; Simulation; Pathologic complete response; Prognostic Biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：57 / 66
页数：9
相关论文
共 50 条
  • [21] A SIMULATION MODELING STUDY TO SUPPORT PERSONALIZED BREAST CANCER PREVENTION AND EARLY DETECTION IN HIGH-RISK WOMEN
    Jayasekera, J.
    Zhao, A.
    VALUE IN HEALTH, 2022, 25 (07) : S436 - S436
  • [22] A simulation modeling study to support personalized breast cancer prevention and early detection in high-risk women
    Jayasekera, Jinani
    Zhao, Amy
    CANCER RESEARCH, 2022, 82 (12)
  • [23] Breast cancer risk prediction accuracy in Jewish Israeli high-risk women using the BOADICEA and IBIS risk models
    Laitman, Yael
    Simeonov, Monica
    Keinan-Boker, Lital
    Liphshitz, Irena
    Friedman, Eitan
    GENETICS RESEARCH, 2013, 95 (06) : 174 - 177
  • [24] Adjuvant CMF +/- tamoxifen (TAM) in premenopausal high-risk patients (PHRPs) with early breast cancer
    Andersson, M
    Kamby, C
    Rose, C
    Andersen, J
    Jensen, MB
    Mouridsen, HT
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S40 - S40
  • [25] Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer
    Kyalwazi, Beverly
    Yau, Christina
    Campbell, Michael J.
    Yoshimatsu, Toshio F.
    Chien, A. Jo
    Wallace, Anne M.
    Forero-Torres, Andres
    Pusztai, Lajos
    Ellis, Erin D.
    Albain, Kathy S.
    Blaes, Anne H.
    Haley, Barbara B.
    Boughey, Judy C.
    Elias, Anthony D.
    Clark, Amy S.
    Isaacs, Claudine J.
    Nanda, Rita
    Han, Hyo S.
    Yung, Rachel L.
    Tripathy, Debasish
    Edmiston, Kristen K.
    Viscusi, Rebecca K.
    Northfelt, Donald W.
    Khan, Qamar J.
    Asare, Smita M.
    Wilson, Amy
    Hirst, Gillian L.
    Lu, Ruixiao
    Symmans, William Fraser
    Yee, Douglas
    DeMichele, Angela M.
    van 't Veer, Laura J.
    Esserman, Laura J.
    Olopade, Olufunmilayo I.
    JAMA NETWORK OPEN, 2023, 6 (12) : E2349646
  • [26] Selecting high-risk early breast cancer patients: What to add to the number of metastatic nodes?
    Perrone, F
    Carlomagno, C
    Lauria, R
    DeLaurentiis, M
    Morabito, A
    Panico, L
    Pettinato, G
    Petrella, G
    Gallo, C
    Bianco, AR
    DePlacido, S
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (01) : 41 - 46
  • [27] Optimal Chemotherapy for High-Risk Early-Stage Breast Cancer
    Atkins, Carl D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : E263 - E263
  • [28] Performance of BCRAT in high-risk patients with breast cancer reply
    Terry, Mary Beth
    Liao, Yuyan
    Hopper, John L.
    MacInnis, Robert J.
    LANCET ONCOLOGY, 2019, 20 (06): : E286 - E286
  • [29] The analysis of ATM mutations in high-risk breast cancer patients
    Prokopcova, J.
    Janatova, M.
    Pohlreich, P.
    Matous, B.
    EJC SUPPLEMENTS, 2005, 3 (02): : 79 - 80
  • [30] High Ki-67 as a biomarker for identifying patients with high-risk early breast cancer treated in monarchE
    Fasching, P.
    Harbeck, N.
    Johnston, S.
    Martin, M.
    Toi, M.
    Rastogi, P.
    Song, C.
    Molthrop, D.
    Vuky, J.
    Yamashita, T.
    Jaliffe, G. G.
    Gumus, M.
    Headley, D.
    Wei, R.
    Barriga, S.
    Munoz, M.
    Method, M.
    Andre, V
    Kreipe, H.
    Oshaughnessy, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 244 - 244
12345